Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$243.8M
20M shares
52-week range
$7.29 – $12.97
84% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
XASE
CS
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
www.infusystem.comNo one on the platform currently holds INFU.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 566,809 | $5.2M |
No one on the platform has traded INFU yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$INFU B. Riley Adjusts Price Target on InfuSystem to $20 From $12, Maintains Buy Rating
View on StockTwits ↗$INFU Q2 looks like an inflection point for INFU: the GE and ERP overhangs have materially de-risked, core oncology remains durable, wound care is accelerating, and the company is now showing operating leverage. That Q3 is usually strong seasonally supports the near term set-up. Longer term the company is starting to look like a potential compounder
View on StockTwits ↗$INFU feels stronger than it has any right to be
View on StockTwits ↗Ticker NEXR has barely 550,000 shares outstanding. The only comparable ticker was VEEE and that one ran from 4.10$ to over 51$. NEXR released news on Aug 3rd and is shifting heavily into the AI sector. NEXR has only about 700 watchers on Stocktwits. Took a big position looking to profit massively very soon. $INFU $IMC $PLTR Pile pile
View on StockTwits ↗$INFU New 52 week high. It’s about damn time. 🤨🤣
View on StockTwits ↗$INFU Q2 '26 Earnings Results & Recap InfuSystem reaffirms 2026 full-year guidance, estimating pro-forma net revenue growth between 6% to 8% and continuing to forecast an Adjusted EBITDA margin in the mid to low 20% range.
View on StockTwits ↗$INFU announces its Q2 2026 results will be released on August 4.
View on StockTwits ↗$INFU new Schwab quant rating of A (strongly outperform)
View on StockTwits ↗$INFU InfuSystem operates primarily on a business-to-business (B2B) model, supplying infusion pumps and support services to hospitals, clinics, and oncology centers. While giants like Becton Dickinson and Co. and Medtronic also manufacture infusion devices, they often act as pump manufacturers, whereas InfuSystem stands out by providing multi-vendor service, equipment tracking, and financial leasing solutions.
View on StockTwits ↗$INFU are investors retarded or is management retarded? That is the question
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $145M | +1.0% | $0.46 | $0.45–$0.46 | 26.5× | 3 |
| 2027 | $156M | +7.1% | $0.56 | $0.55–$0.57 | 21.6× | 3 |
| 2028 | $166M | +6.7% | $0.00 | $0.00–$0.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $0.10 | $0.15 | +42.9% |
| 2026-05-07 | $0.04 | $0.05 | +25.0% |
| 2026-02-24 | $0.07 | $0.10 | +42.9% |
| 2025-11-04 | $0.08 | $0.11 | +37.5% |
| 2025-08-05 | $0.03 | $0.12 | +300.0% |
| 2025-05-08 | $-0.03 | $-0.01 | +66.7% |
| 2025-03-04 | $0.08 | $0.04 | -50.0% |
| 2024-11-07 | $0.06 | $0.08 | +33.3% |
| $153M |
| — |
| NNOXNano-X Imaging Ltd. | $0.98 | -3.43% | $69M | — |
| NYXHNyxoah S.A. | $1.58 | +0.00% | $158M | — |
Source: Financial Modeling Prep · peers by sector/industry